Overview
- Contact person: Prof. Haueisen, Institute Director and Head of Biomedical Engineering Group BMTI, TU Ilmenau
- Project staff: Herr Link, Herr Dr. Klee, Frau Kuhne, Herr Matthias Hillenbrand, Frau. Dr. Beate Mitschunas
- Project description:
In Germany, about 4.5 Million people suffer from age-related macular degeneration (AMD). AMD yields in its late phases a complete loss of the function of the central retina and thus the central sight. A patient quotation: "At places where I try to look closely, I cannot see anything anymore." There is no therapy available for AMD. The primary aim of our research group is the development of a novel optical rehabilitation to improve vision in AMD patients. The technological approach is based on innovative free-form optic. Moreover, we will develop novel training schemes for patients with the new rehabilitation devices based on neuro-scientific investigations.
Unternehmensbeirat für 2012 FGR 0014:
Vorsitz:
Mitglieder:
- asphericon GmbH (Sven R. Kiontke, Jena)
- Augenarztpraxis Dr. Nagel (Dr. Edgar Nagel, Rudolstadt)
- Carl Zeiss Meditec AG (Dr. Manfred Dick, Jena)
- Neuroconn (Klaus Schellhorn, Ilmenau)
- OphthalmoInnovation GmbH (Volker Wiechmann, Jena)
- Optik Elstner (Andreas Gortan, Ilmenau)
23rd Meeting of the Ophthalmic Optics Working Group (AOO) 24.-10.October 2014 in Ilmenau (Germany)The 23rd meeting of the Ophthalmic Optics Working Group took place in Ilmenau from October 24th to 26th, 2014 and was chaired by Dr. Sascha Klee and DI Dietmar Link organize and host.49 participants from all over Germany discussed current technical problems in ophthalmology.